|
CLASP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.18520037807014E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.33479998960007E-09 |
| Normal-vs-Stage2 |
4.058300E-03 |
| Normal-vs-Stage3 |
2.39869999973941E-07 |
| Normal-vs-Stage4 |
1.49290000028834E-07 |
| Stage1-vs-Stage2 |
8.684000E-01 |
| Stage1-vs-Stage3 |
2.770200E-01 |
| Stage1-vs-Stage4 |
2.277600E-01 |
| Stage2-vs-Stage3 |
2.861800E-01 |
| Stage2-vs-Stage4 |
1.976010E-01 |
| Stage3-vs-Stage4 |
5.355000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04639963360853E-10 |
| Normal-vs-AfricanAmerican |
2.743400E-03 |
| Normal-vs-Asian |
2.498400E-01 |
| Caucasian-vs-AfricanAmerican |
3.202800E-01 |
| Caucasian-vs-Asian |
6.863800E-01 |
| AfricanAmerican-vs-Asian |
9.546800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.41859915112764E-12 |
| Normal-vs-Female |
3.156000E-02 |
| Male-vs-Female |
1.404050E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.599660E-03 |
| Normal-vs-Extreme_Weight |
9.21640541662327E-12 |
| Normal-vs-Obese |
4.06600000002477E-07 |
| Normal-vs-Extreme_Obese |
6.519700E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.640600E-01 |
| Normal_Weight-vs-Obese |
9.488200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.892400E-01 |
| Extreme_Weight-vs-Obese |
1.869970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.683600E-01 |
| Obese-vs-Extreme_Obese |
7.192200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.657600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.80660000004274E-06 |
| Normal-vs-Age(61-80Yrs) |
2.33839947405556E-10 |
| Normal-vs-Age(81-100Yrs) |
9.80940000000485E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.449400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.621800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.792800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.255200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.803800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.220000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.87679999214186E-09 |
| Normal-VS-Type2 PRCC |
4.11369999997468E-06 |
| Normal-VS-KIRP CIMP |
2.45349999999922E-05 |
| Normal-VS-Unclassified PRCC |
1.964370E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.743400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.290600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.298800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.316000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.666800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.342000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9886999824692E-09 |
| Normal-vs-N1 |
1.93910000279018E-08 |
| Normal-vs-N2 |
1.100810E-01 |
| N0-vs-N1 |
9.208600E-01 |
| N0-vs-N2 |
7.400800E-01 |
| N1-vs-N2 |
7.448600E-01 |
|
|
